Detalhe da pesquisa
1.
Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer.
N Engl J Med
; 380(24): 2317-2326, 2019 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31189035
2.
Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study.
Gynecol Oncol
; 164(2): 428-436, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34903380
3.
A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study.
Gynecol Oncol
; 164(3): 481-491, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35063278
4.
Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study.
Gynecol Oncol
; 161(1): 113-121, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33541735
5.
Progress in endometrial cancer: Contributions of the former Gynecologic Oncology Group.
Gynecol Oncol
; 157(2): 312-322, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32014330
6.
An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275.
Gynecol Oncol
; 158(2): 354-360, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32460997
7.
Disparities in health-related quality of life in women undergoing treatment for advanced ovarian cancer: the role of individual-level and contextual social determinants.
Support Care Cancer
; 27(2): 531-538, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30003341
8.
A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer.
Gynecol Oncol
; 150(2): 274-281, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29804638
9.
Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.
Cancer
; 123(7): 1144-1155, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27926776
10.
High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study.
Gynecol Oncol
; 146(2): 247-253, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28532857
11.
Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol.
Gynecol Oncol
; 145(3): 519-525, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28392124
12.
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 141(1): 43-8, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27016228
13.
Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study 0229N.
Gynecol Oncol
; 138(1): 24-9, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25888978
14.
Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study.
Gynecol Oncol
; 132(3): 585-92, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24456823
15.
Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study.
Gynecol Oncol
; 125(1): 87-93, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22155678
16.
Effects of Slide Storage on Detection of Molecular Markers by IHC and FISH in Endometrial Cancer Tissues From a Clinical Trial: An NRG Oncology/GOG Pilot Study.
Appl Immunohistochem Mol Morphol
; 30(1): 27-35, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34224438
17.
Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial.
J Clin Oncol
; 40(9): 968-977, 2022 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35007153
18.
TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.
J Clin Oncol
; 40(28): 3289-3300, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35658479
19.
Phase II study of fulvestrant in recurrent/metastatic endometrial carcinoma: a Gynecologic Oncology Group study.
Gynecol Oncol
; 120(2): 185-8, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21075433
20.
A Surgical Window Trial Evaluating Medroxyprogesterone Acetate with or without Entinostat in Patients with Endometrial Cancer and Validation of Biomarkers of Cellular Response.
Clin Cancer Res
; 27(10): 2734-2741, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33766814